Search Results 391-400 of 37513 for Two-phase

1. End-stage renal disease - Symptoms and causes - Mayo Clinic

   Diseases and conditions that can lead to kidney disease include: Type 1 or type 2 diabetes; High blood pressure; Glomerulonephritis (gloe-mer-u-low-nuh-FRY-tis) ...

2. Radiation Clinical Trials - Mayo Clinic Research

   Single-arm phase 2 study to examine pembrolizumab and concurrent ... There are two study questions we are asking in this randomized phase II/III ...

3. Chemotherapy Clinical Trials - Mayo Clinic Research

   PURPOSE: Randomized phase III trial to compare the effectiveness of two different regimens of combination chemotherapy in treating women who have stage II ...

4. A Study Of GC012F (AZD0120), A CAR T Therapy Targeting CD19 And BCMA In Subjects With Relapsed/Refractory Multiple Myeloma - Mayo Clinic

   This trial is a phase 1b/2, open-label, multicenter study of GC012F (AZD0120), a CD19/BCMA dual CART-cell therapy, in adult subjects with relapsed/refractory ...

5. A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis) - Mayo Clinic

   The purpose of this study will assess the efficacy and safety of 2 dose regimens of pegozafermin for the treatment of liver fibrosis stage 2 or 3 in adult ...

6. A Study to Evaluate the Effects of Two Doses of MBX-8025 in Subjects with Primary Biliary Cirrhosis - Mayo Clinic

   Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

7. A Study to Evaluate RP1 Monotherapy and Combined with Nivolumab - Mayo Clinic

   ... Phase 2 dose (RP2D), as well as to evaluate preliminary effectiveness. Participation eligibility. Participant eligibility includes age, gender, type and ...

8. Treatment of Muscle Cramps in Patients with Liver Cirrhosis - Mayo Clinic

   Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

9. Safety and Efficacy Study of MLN0128 in Combination With Exemestane or Fulvestrant in Postmenopausal Women With ER/PR+ Metastatic Breast Cancer - Mayo Clinic

   This is a phase 1b/2 study of the safety and efficacy of MLN0128 in combination with exemestane or fulvestrant therapy in women with estrogen receptor positive/ ...

10. AI-powered imaging tool enhances detection of surgical site infections - Mayo Clinic

    The two-stage model demonstrates high accuracy in identifying incisions and postoperative infections from patient-submitted images.